Zoetis
Manufacturing · New Jersey, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
10 Sylvan Way, Parsippany, New Jersey, 0...Phone Number
(973) 822-7000Website
www.zoetis.comRevenue
$9.5 BillionStock Symbol
ZTSIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
17
17
1
3
3
2
About Zoetis
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.Explore more
Zoetis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zoetis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Zoetis launches new products
Click to see if Zoetis had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Zoetis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Zoetis
Check out if Zoetis is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Zoetis has new funding data
Zoetis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Zoetis recently announced quarterly report
Recommended Actions
Find VP level buyers at Zoetis
Find 3 more new buyers
Compare Similar Companies to Zoetis
Compare insights from companies similar to Zoetis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zoetis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zoetis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zoetis.
Zoetis financials insights
Gather financial insights about Zoetis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$2.2B
2023
Grant
$15.3M
Zoetis Tech Stack
A closer look at the technologies used by Zoetis
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Person-Based
Earnings, Lawsuits, Legal Affairs, Finance
Zoetis News & Media
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC
Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: Juy 27, 2026 Key...ZOETIS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.ZTS INVESTOR NOTICE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
SAN DIEGO, June 18, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), have until Monday, July 27, 2026 to seek appointment as lead...NYSE: ZTS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Zoetis Inc.
Did you buy ZTS securities between January 14, 2025, and May 6, 2026?
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zoetis
Sign Up For FreeTo access detailed company insights
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The comp... Read More
